Savas, E. M. Et Al. 2020. Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. METABOLIC SYNDROME AND RELATED DISORDERS , vol.18, no.4 , 197-205.

Savas, E. M., Oguz, S. H., Samadi, A., YILMAZ IŞIKHAN, S., ÜNLÜTÜRK, U., LAY, İ., ... Gurlek, A.(2020). Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study. METABOLIC SYNDROME AND RELATED DISORDERS , vol.18, no.4, 197-205.

Savas, EMİNE Et Al. "Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study," METABOLIC SYNDROME AND RELATED DISORDERS , vol.18, no.4, 197-205, 2020

Savas, EMİNE M. Et Al. "Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study." METABOLIC SYNDROME AND RELATED DISORDERS , vol.18, no.4, pp.197-205, 2020

Savas, E. M. Et Al. (2020) . "Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study." METABOLIC SYNDROME AND RELATED DISORDERS , vol.18, no.4, pp.197-205.

@article{article, author={EMİNE MERVE SAVAŞ Et Al. }, title={Apoptosis Inhibitor of Macrophage, Monocyte Chemotactic Protein-1, and C-Reactive Protein Levels Are Increased in Patients with Metabolic Syndrome: A Pilot Study}, journal={METABOLIC SYNDROME AND RELATED DISORDERS}, year=2020, pages={197-205} }